Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Democratic Republic of the Congo: a Randomized Controlled Trial (TES2022)

NCT06076213 is registered in ClinicalTrials.gov with Ministry of Public Health, Democratic Republic of the Congo as lead sponsor.

NCT NCT06076213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06076213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Democratic Republic of the Congo: a Randomized Controlled Trial (TES2022)
Lead sponsor
Ministry of Public Health, Democratic Republic of the Congo
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2023
Completion date
September 30, 2024
Enrollment
1,260 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated plasmodium falciparum malaria